Supplementary Figure S4 from Prognostic Markers of DNA Methylation and Next-Generation Sequencing in Progressive Glioblastoma from the EORTC-26101 Trial

<p>Supplementary Figure 4: Multivariate analysis. Baselines were MGMT = “methylated” and Classifier = “GBM MES”. Classifier assignment is based on the v12.5 version (n = 380).</p>

-д хадгалсан:

Номзүйн дэлгэрэнгүй
Үндсэн зохиолч:	Tobias Kessler (17079209) (author)
Бусад зохиолчид:	Daniel Schrimpf (17079212) (author), Laura Doerner (17079215) (author), Ling Hai (17079218) (author), Leon D. Kaulen (17079221) (author), Jakob Ito (17079224) (author), Martin van den Bent (17079227) (author), Martin Taphoorn (17079230) (author), Alba A. Brandes (17079233) (author), Ahmed Idbaih (17079236) (author), Julien Dômont (17079239) (author), Paul M. Clement (15044256) (author), Mario Campone (15027156) (author), Martin Bendszus (17079242) (author), Andreas von Deimling (15037904) (author), Felix Sahm (15097382) (author), Michael Platten (15018165) (author), Wolfgang Wick (15018168) (author), Antje Wick (17079245) (author)
Хэвлэсэн:	2025
Нөхцлүүд:	Cancer Cancer Detection and Diagnosis Clinical Research and Trials Methods and Technology Biomarkers Epigenetic biomarkers Prognostic biomarkers CNS Cancers Gliomas, Glioblastomas Computational Methods Sequence analysis Precision Medicine
Шошгууд:	Шошго нэмэх Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!

_version_	1849927632745922560
author	Tobias Kessler (17079209)
author2	Daniel Schrimpf (17079212) Laura Doerner (17079215) Ling Hai (17079218) Leon D. Kaulen (17079221) Jakob Ito (17079224) Martin van den Bent (17079227) Martin Taphoorn (17079230) Alba A. Brandes (17079233) Ahmed Idbaih (17079236) Julien Dômont (17079239) Paul M. Clement (15044256) Mario Campone (15027156) Martin Bendszus (17079242) Andreas von Deimling (15037904) Felix Sahm (15097382) Michael Platten (15018165) Wolfgang Wick (15018168) Antje Wick (17079245)
author2_role	author author author author author author author author author author author author author author author author author author
author_facet	Tobias Kessler (17079209) Daniel Schrimpf (17079212) Laura Doerner (17079215) Ling Hai (17079218) Leon D. Kaulen (17079221) Jakob Ito (17079224) Martin van den Bent (17079227) Martin Taphoorn (17079230) Alba A. Brandes (17079233) Ahmed Idbaih (17079236) Julien Dômont (17079239) Paul M. Clement (15044256) Mario Campone (15027156) Martin Bendszus (17079242) Andreas von Deimling (15037904) Felix Sahm (15097382) Michael Platten (15018165) Wolfgang Wick (15018168) Antje Wick (17079245)
author_role	author
dc.creator.none.fl_str_mv	Tobias Kessler (17079209) Daniel Schrimpf (17079212) Laura Doerner (17079215) Ling Hai (17079218) Leon D. Kaulen (17079221) Jakob Ito (17079224) Martin van den Bent (17079227) Martin Taphoorn (17079230) Alba A. Brandes (17079233) Ahmed Idbaih (17079236) Julien Dômont (17079239) Paul M. Clement (15044256) Mario Campone (15027156) Martin Bendszus (17079242) Andreas von Deimling (15037904) Felix Sahm (15097382) Michael Platten (15018165) Wolfgang Wick (15018168) Antje Wick (17079245)
dc.date.none.fl_str_mv	2025-11-25T13:22:35Z
dc.identifier.none.fl_str_mv	10.1158/1078-0432.30708535
dc.relation.none.fl_str_mv	https://figshare.com/articles/figure/Supplementary_Figure_S4_from_Prognostic_Markers_of_DNA_Methylation_and_Next-Generation_Sequencing_in_Progressive_Glioblastoma_from_the_EORTC-26101_Trial/30708535
dc.rights.none.fl_str_mv	CC BY info:eu-repo/semantics/openAccess
dc.subject.none.fl_str_mv	Cancer Cancer Detection and Diagnosis Clinical Research and Trials Methods and Technology Biomarkers Epigenetic biomarkers Prognostic biomarkers CNS Cancers Gliomas, Glioblastomas Computational Methods Sequence analysis Precision Medicine
dc.title.none.fl_str_mv	Supplementary Figure S4 from Prognostic Markers of DNA Methylation and Next-Generation Sequencing in Progressive Glioblastoma from the EORTC-26101 Trial
dc.type.none.fl_str_mv	Image Figure info:eu-repo/semantics/publishedVersion image
description	<p>Supplementary Figure 4: Multivariate analysis. Baselines were MGMT = “methylated” and Classifier = “GBM MES”. Classifier assignment is based on the v12.5 version (n = 380).</p>
eu_rights_str_mv	openAccess
id	Manara_b750772dfdc4f57c0198842ce1430543
identifier_str_mv	10.1158/1078-0432.30708535
network_acronym_str	Manara
network_name_str	ManaraRepo
oai_identifier_str	oai:figshare.com:article/30708535
publishDate	2025
repository.mail.fl_str_mv
repository.name.fl_str_mv
repository_id_str
rights_invalid_str_mv	CC BY
spelling	Supplementary Figure S4 from Prognostic Markers of DNA Methylation and Next-Generation Sequencing in Progressive Glioblastoma from the EORTC-26101 TrialTobias Kessler (17079209)Daniel Schrimpf (17079212)Laura Doerner (17079215)Ling Hai (17079218)Leon D. Kaulen (17079221)Jakob Ito (17079224)Martin van den Bent (17079227)Martin Taphoorn (17079230)Alba A. Brandes (17079233)Ahmed Idbaih (17079236)Julien Dômont (17079239)Paul M. Clement (15044256)Mario Campone (15027156)Martin Bendszus (17079242)Andreas von Deimling (15037904)Felix Sahm (15097382)Michael Platten (15018165)Wolfgang Wick (15018168)Antje Wick (17079245)CancerCancer Detection and DiagnosisClinical Research and TrialsMethods and TechnologyBiomarkersEpigenetic biomarkersPrognostic biomarkersCNS CancersGliomas, GlioblastomasComputational MethodsSequence analysisPrecision Medicine<p>Supplementary Figure 4: Multivariate analysis. Baselines were MGMT = “methylated” and Classifier = “GBM MES”. Classifier assignment is based on the v12.5 version (n = 380).</p>2025-11-25T13:22:35ZImageFigureinfo:eu-repo/semantics/publishedVersionimage10.1158/1078-0432.30708535https://figshare.com/articles/figure/Supplementary_Figure_S4_from_Prognostic_Markers_of_DNA_Methylation_and_Next-Generation_Sequencing_in_Progressive_Glioblastoma_from_the_EORTC-26101_Trial/30708535CC BYinfo:eu-repo/semantics/openAccessoai:figshare.com:article/307085352025-11-25T13:22:35Z
spellingShingle	Supplementary Figure S4 from Prognostic Markers of DNA Methylation and Next-Generation Sequencing in Progressive Glioblastoma from the EORTC-26101 Trial Tobias Kessler (17079209) Cancer Cancer Detection and Diagnosis Clinical Research and Trials Methods and Technology Biomarkers Epigenetic biomarkers Prognostic biomarkers CNS Cancers Gliomas, Glioblastomas Computational Methods Sequence analysis Precision Medicine
status_str	publishedVersion
title	Supplementary Figure S4 from Prognostic Markers of DNA Methylation and Next-Generation Sequencing in Progressive Glioblastoma from the EORTC-26101 Trial
title_full	Supplementary Figure S4 from Prognostic Markers of DNA Methylation and Next-Generation Sequencing in Progressive Glioblastoma from the EORTC-26101 Trial
title_fullStr	Supplementary Figure S4 from Prognostic Markers of DNA Methylation and Next-Generation Sequencing in Progressive Glioblastoma from the EORTC-26101 Trial
title_full_unstemmed	Supplementary Figure S4 from Prognostic Markers of DNA Methylation and Next-Generation Sequencing in Progressive Glioblastoma from the EORTC-26101 Trial
title_short	Supplementary Figure S4 from Prognostic Markers of DNA Methylation and Next-Generation Sequencing in Progressive Glioblastoma from the EORTC-26101 Trial
title_sort	Supplementary Figure S4 from Prognostic Markers of DNA Methylation and Next-Generation Sequencing in Progressive Glioblastoma from the EORTC-26101 Trial
topic	Cancer Cancer Detection and Diagnosis Clinical Research and Trials Methods and Technology Biomarkers Epigenetic biomarkers Prognostic biomarkers CNS Cancers Gliomas, Glioblastomas Computational Methods Sequence analysis Precision Medicine

Supplementary Figure S4 from Prognostic Markers of DNA Methylation and Next-Generation Sequencing in Progressive Glioblastoma from the EORTC-26101 Trial

Ижил төстэй зүйлс